Oklahoma Cancer Specialists and Research Institute

GOG-3116 (C5721005): A Prospective Low-Interventional Phase 4 Single Arm Study of Ocular Assessments in Patients Treated with Tivdak in Recurrent or Metastatic Cervical Cancer

Cervical Cancer Recruiting Multiple locations

Disease: Cervical Cancer

Eligibility Criteria: None

NCT: 07216703

Inclusion:    

  • Recurrent or Metastatic cervical cancer with disease progression on/after chemotherapy

  • Initiating Tivdak

 



View Full Trial Details

Have questions about participation?

Our clinical research team is happy to answer questions about eligibility, the study process, or next steps.

Contact the Research Team

Privacy Choices

Cookie and Tracking Consent

Oklahoma Cancer Specialists and Research Institute uses cookies and similar tracking technologies to keep this site functioning and, with your permission, to measure traffic and improve the experience. By clicking Accept, you consent to analytics and tracking cookies. By clicking Decline, only essential site functionality will remain enabled.

See our Privacy Policy for more information.